Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Niu, Yuanjie ^a,b   Wang, Juan ^a   Shang, Zhiqun ^a,b   Huang, Shu Pin ^b   Shyr, Chih Rong ^c   Yeh, Shuyuan ^b   Chang, Chawnshang ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYTOKERATIN 5; CYTOKERATIN 8; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASAL CELL; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MALE; MOLECULAR MECHANICS; MORPHOGENESIS; MOUSE; NONHUMAN; ORGANOGENESIS; PROSTATE DEVELOPMENT; PROSTATE EPITHELIUM; SMOOTH MUSCLE FIBER; STROMA CELL; TISSUE INTERACTION; ANIMAL; ATROPHY; C57BL MOUSE; GENE INACTIVATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; PROSTATE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS;

ANIMALS; APOPTOSIS; ATROPHY; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELLS; GENE KNOCKOUT TECHNIQUES; HUMANS; KERATIN-5; KERATIN-8; MALE; MICE; MICE, INBRED C57BL; MORPHOGENESIS; MYOCYTES, SMOOTH MUSCLE; PROSTATE; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79959922580     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020202     Document Type: Article

References (38)

1. Cunha GR, Ricke W, Thomson A, (2004) Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. The Journal of Steroid Biochemistry and Molecular Biology 92 (4): 221-36.
2. Kim IY, Ahn H-J, Zelner DJ, Park L, Sensibar JA, et al. (1996) Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression. Mol Endocrinol 10: 107-15.
3. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Lang S, et al. (1996) Loss of expression of transforming growth factor type I and type II receptors correlates with tumor grade in human prostate cancer tissue. Clin Cancer Res 2: 1255-1261.
4. Williams RH, Stapleton AMF, Yang G, Truong LD, Rogers E, et al. (1996) Reduced levels of transforming growth factor b receptor type II in human prostate cancer: an immunohistochemical study. Clinical cancer research 2: 635-640.
5. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, et al. (1990) Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia. Prostate 16: 71-80.
6. Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK, (1993) Influence of transforming growth factor b1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 22: 183-197.
7. Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM, et al. (1996) Stromal cells of the human prostate: Initial isolation and characterization. Prostate 28: 89-97.
8. Klingler HC, Bretland AJ, Reid SV, Chapple CR, Eaton CL, (1999) Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGF-beta). Prostate 41: 110-20.
9. Peehl DM, Sellers RG, (1997) Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Exp Cell Res 232: 208-215.
10. Niu Y, Xu Y, Zhang J, Bai J, Yang H, et al. (2001) Proliferation and differentiation of prostate stromal cells. BJU int 87: 386-393.
11. Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N, (2008) TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate 68: 287-95.
12. Huang X, Lee C, (2003) Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta. Front Biosci 8: s740-9.
13. Cunha GR, (1976) Epithelial-stromal interactions in development of the urogenital tract. Int Rev Vytol 47: 137.
14. Cunha GR, Lung B, (1978) The possible influences of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitve (Tfm) mice. J Exp Zool 205: 343.
15. Cunha GR, Chung LWK, (1981) Stromal-epithelial interactions: Induction of prostatic phenotype in urothelium of testicular feminized (Tfm) mice. J Steroid Biochem 14: 1317.
16. Cunha GR, Chung LWK, Shannon JM, Taguchi O, Fujii H, (1983) Hormonal induced morphogenesis and growth: Role of the mesenchymal-epithelial interactions. Recent Prog Horm Res 39: 559.
17. Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, et al. (2007) Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci USA 104: 12679-84.
18. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, et al. (2007) Prostate Cancer Stem/Progenitor Cells: Identification, Characterization, and Implications. Molecular Carcinogenesis 46: 1-14.
19. Hartsock A, Nelson WJ, (2008) Adherens and Tight Junctions: Structure, Function and Connections to the Actin Cytoskeleton. Biochim Biophys Acta 1778 (3): 660-669.
20. McNeal JE, (1983) The prostate gland: Morphology and pathobiology. Monographs in Urology, Vol 4, No 1.
21. Nemeth JA, Sensibar JA, White RR, Zelner DJ, Kim IY, et al. (1997) Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-beta 1. Prostate 33: 64-71.
22. Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier HU, et al. (1998) Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 63: 131-40.
23. Perry KT, Anthony CT, Steiner MS, (1997) Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate. Prostate 33 (2): 133-40.
24. Cardillo MR, Petrangeli E, Salvatori L, Ravenna L, Di Silverio F, (2000) Transforming growth factor beta 1 and androgen receptors in prostate neoplasia. Anal Quant Cytol Histol 22: 403-10.
25. Story MT, Hopp KA, Molter M, (1996) Expression of transforming growth factor beta 1 (TGF beta 1),-beta 2, and- beta 3 by cultured human prostate cells. J Cell Physiol 169: 97-107.
26. Salm SN, Koikawa Y, Ogilvie V, Tsujimura A, Coetzee S, et al. (2000) Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines. J Cell Physiol 184 (1): 70-9.
27. Danielpour D, (1996) Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha, 25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J Cell Physiol 166: 231-9.
28. Raghow S, Shapiro E, Steiner MS, (1999) Immunohistochemical localization of transforming growth factor-alpha and transforming growth factor-beta during early human fetal prostate development. J Urol 162: 509-13.
29. Zhao H, Patra A, Yeh CC, Tanaka Y, Oh BR, et al. (2002) Effects of aging on growth factors gene and protein expression in the dorsal and ventral lobes of rat prostate. Biochem Biophys Res Commun 292: 482-91.
30. Barron DA, Strand DW, Ressler SJ, Dang TD, Hayward SW, et al. (2010) TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One 5: e13751.
31. Robinson EJ, Neal DE, Collins AT, (1998) Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37: 149-60.
32. Xue Y, Smedts F, Debruyne FM, de la Rosette JJ, Schalken JA, (1998) Identiffication of intermediate cell types by keratin expression in the developing human prostate. Prostate 34: 292-301.
33. Wang Y, Hayward S, Cao M, Thayer K, Cunha G, (2001) Cell differentiation lineage in the prostate. Differentiation 68 (4/5): 270-9.
34. Blanpain C, Horsley V, Fuchs E, (2007) Epithelial stem cells: turning over new leaves. Cell 128: 445-458.
35. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
36. Litvinov IV, De Marzo AM, Isaacs JT, (2003) Is the Achilles' heel for prostate cancer therapy: a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 88: 2972-2982.
37. Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, et al. (2008) Androgen receptor is a tumor suppressor and proliferators in prostate cancer. PNAS 105: 12182-12187.
38. Niu Y, Altuwaijri S, Yeh S, Lai KP, Yu S, et al. (2008) Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. PNAS 105: 12188-12193.